Last reviewed · How we verify
Tacrolimus, Myfortic and Sirolimus
Tacrolimus, Myfortic and Sirolimus is a Small molecule drug developed by University of Miami. It is currently FDA-approved.
At a glance
| Generic name | Tacrolimus, Myfortic and Sirolimus |
|---|---|
| Sponsor | University of Miami |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy (PHASE3)
- A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256) (PHASE2)
- Allo HSCT for High Risk Hemoglobinopathies (PHASE2)
- Advancing Transplantation Outcomes in Children (PHASE2)
- Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies (PHASE1, PHASE2)
- Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer (PHASE4)
- The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients (PHASE2)
- Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tacrolimus, Myfortic and Sirolimus CI brief — competitive landscape report
- Tacrolimus, Myfortic and Sirolimus updates RSS · CI watch RSS
- University of Miami portfolio CI
Frequently asked questions about Tacrolimus, Myfortic and Sirolimus
What is Tacrolimus, Myfortic and Sirolimus?
Tacrolimus, Myfortic and Sirolimus is a Small molecule drug developed by University of Miami.
Who makes Tacrolimus, Myfortic and Sirolimus?
Tacrolimus, Myfortic and Sirolimus is developed and marketed by University of Miami (see full University of Miami pipeline at /company/university-of-miami).
What development phase is Tacrolimus, Myfortic and Sirolimus in?
Tacrolimus, Myfortic and Sirolimus is FDA-approved (marketed).